Pfizer transfers Upjohn business to Mylan Pharmaceuticals for Rs 180.48 crore

02 Aug 2022 Evaluate

Pfizer has transferred its certain primarily off-patent branded and generic established medicines business (Upjohn Business) comprising of six brands which included Lyrica, Viagra, Celebrex, Amlogard, Daxid and Dilantin along with related business assets and liabilities to Mylan Pharmaceuticals, effective August 1, 2022. Accordingly, the Company has received the purchase consideration of Rs 180.48 crore from Mylan Pharmaceuticals. Earlier, the company had entered into a business transfer agreement (BTA) with Mylan Pharmaceuticals.

Pfizer has produced innovative breakthroughs in a wide range of research areas, including depression, erectile dysfunction, high cholesterol, HIV infection, hypertension, bacterial infections and systemic fungal infections.

Pfizer Share Price

5049.50 17.75 (0.35%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×